{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:53:18Z","timestamp":1784008398357,"version":"3.55.0"},"reference-count":15,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2004,6,4]]},"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:sec>\n                  <jats:title>Backgound<\/jats:title>\n                  <jats:p>Endometriosis is one of the commonest benign gynaecological disorders and has a peak incidence between 30 and 45 years of age. Treatment options are medical or surgical, depending on the location and extent of the disease and the woman's childbearing aspirations or need for contraception. Over the past five decades several formulations of progestogen have been used to treat endometriosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Our study was not planned research but a series of case studies of women with severe symptoms of endometriosis treated in an innovative way with a new long-acting progestogen contraceptive system (etonogestrel subdermal implant) which could reasonably have been expected to have a favourable effect on their disease and its symptoms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Five women with severe pelvic endometriosis were treated. Two of them were nulliparous and wished to become pregnant in due course; the other three had completed their childbearing and were contemplating hysterectomy. One of the five women had relief of pelvic pain but requested removal of the implant after 3 months because of side effects; the other four remained very satisfied with their treatment for the symptoms of pelvic endometriosis. Two of the four very satisfied women have had their implant replaced and the other two are expected to have their implant replaced when necessary.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Etonogestrel subdermal implants are an additional treatment option in women with symptoms related to pelvic endometriosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1783\/0000000052972799","type":"journal-article","created":{"date-parts":[[2005,3,5]],"date-time":"2005-03-05T01:30:57Z","timestamp":1109986257000},"page":"67-70","source":"Crossref","is-referenced-by-count":48,"title":["Treatment of pelvic endometriosis with etonogestrel subdermal implant (Implanon\u00ae)"],"prefix":"10.1136","volume":"31","author":[{"given":"Solomon B","family":"Yisa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela A","family":"Okenwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy P","family":"Husemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2005,1,1]]},"reference":[{"key":"ref_1","article-title":"Gynaecology","author":"In, Shaw R.W.Endometriosis","year":"2003","unstructured":"Shaw RW. Endometriosis. In: Shaw RW, Soutter WP, Stanton S (eds), Gynaecology (3rd edn). London, UK: Churchill Livingstone, 2003; 510.","edition":"3rd edn"},{"issue":"36","key":"ref_2","first-page":"745","article-title":"Uber den Staude der Frage der Adenomyosites Adenomyoma in Allgemeinen und Insbesondere uber Adenomyosites seroepitheliolis Adenomyometitis Sarcomatosa","volume":"1919","author":"Meyer, R.","unstructured":"Meyer R. Uber den Staude der Frage der Adenomyosites Adenomyoma in Allgemeinen und Insbesondere uber Adenomyosites seroepitheliolis Adenomyometitis Sarcomatosa. Zentralbl Gynakol 1919; 36: 745\u2013759.","journal-title":"Zentralbl Gynakol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archsurg.1921.01110080003001","article-title":"Perforating haemorrhagic (chocolate) cysts of the ovary, their importance and especially their relation to pelvic adenomas of the endometrial type","volume":"3","author":"Sampson, J.A.","year":"1927","unstructured":"Sampson JA. Perforating haemorrhagic (chocolate) cysts of the ovary, their importance and especially their relation to pelvic adenomas of the endometrial type. Arch Surg 1927; 3: 245\u2013323.","journal-title":"Arch Surg"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1471-0528.2004.00061x.x","article-title":"Treatment of endometriotic catamenial haemoptysis with etonogestrel subdermal implant","volume":"111","author":"Yisa, S.B.; Okenwa, A.A.; Husemeyer, R.P.","year":"2004","unstructured":"Yisa SB, Okenwa AA, Husemeyer RP. Treatment of endometriotic catamenial haemoptysis with etonogestrel subdermal implant. Br J Obstet Gynaecol 2004; 111: 385\u2013386.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_5","article-title":"Medical and endocrine modulatory treatments","author":"Lindsay, P.C.","year":"1994","unstructured":"Lindsay PC. Medical and endocrine modulatory treatments. In: Shaw RW (ed.), Endometriosis. Oxford, UK: Blackwell Science, 1994; 193\u2013195."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0002-9378(58)90384-3","article-title":"The use of newer progestins in the treatment of endometriosis","volume":"75","author":"Kistner, R.","year":"1958","unstructured":"Kistner R. The use of newer progestins in the treatment of endometriosis. Am J Obstet Gynecol 1958; 75: 264\u2013278.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_7","first-page":"265","article-title":"Management of endometriosis with oral medroxyprogesterone acetate","volume":"47","author":"Moghissi, K.S.; Boyce, C.R.","year":"1976","unstructured":"Moghissi KS, Boyce CR. Management of endometriosis with oral medroxyprogesterone acetate. Obstet Gynecol 1976; 47: 265\u2013267.","journal-title":"Obstet Gynecol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1471-0528.1976.tb00734.x","volume":"83","author":"Dydrogesterone, Johnston W.I.; endometriosis","year":"1976","unstructured":"Johnston WI. Dydrogesterone and endometriosis. Br J Obstet Gynaecol 1976; 83: 77\u201380.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09513598709082692","article-title":"Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis","volume":"1","author":"Telimaa, S.; Puolakka, J.; Ronuberg, L.; Kauppila, A.","year":"1987","unstructured":"Telimaa S, Puolakka J, Ronuberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1987; 1: 13\u201323.","journal-title":"Gynecol Endocrinol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9378(96)70152-7","article-title":"Depot medroxyprogesterone acetate versus an oral contraceptive combined with very low dose danazol for long-term treatment of pelvic pain associated with endometriosis","volume":"175","author":"Vercellini, P.; Di Giorgi, O.; Oldani, S.; Cortesi, I.; Panazza, S.; Crosignani, P.G.","year":"1996","unstructured":"Vercellini P, Di Giorgi O, Oldani S, Cortesi I, Panazza S, Crosignani PG. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very low dose danazol for long-term treatment of pelvic pain associated with endometriosis. Am J Obstet Gynecol 1996; 175: 396\u2013401.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_11","first-page":"714","article-title":"Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant","volume-title":"Fertil Steril","volume":"69","author":"Makarainen, L.; van Beek, A.; Tuomivaara, L.; Asplund, B.; Bennink, H.C.","year":"1998","unstructured":"Makarainen L, van Beek A, Tuomivaara L, Asplund B, Bennink HC. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril 1998; 69: 714\u2013721."},{"issue":"91","key":"ref_12","first-page":"13","article-title":"The pharmacodynamics and efficacy of Implanon. An overview of the data","volume":"58","author":"Croxatto, H.B.; Makarainen, L.","year":"1998","unstructured":"Croxatto HB, Makarainen L. The pharmacodynamics and efficacy of Implanon. An overview of the data. Contraception 1998; 58: 91S\u201397S. 13 Bennink HJ. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 2000; 5(Suppl. 2): 12\u201320.","journal-title":"Contraception; The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant"},{"key":"ref_13","first-page":"3","article-title":"A review of clinical studies","volume":"24","author":"Edwards, J.E.; Implanon, Moore A.","year":"1999","unstructured":"Edwards JE, Moore A. Implanon. A review of clinical studies. Br J Fam Plann 1999; 24: 3\u201316.","journal-title":"Br J Fam Plann"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/fampra\/cmh509","article-title":"Journal Club Opening a can of worms\u201d: GP and practice nurse barriers to talking about sexual health in primary","volume":"21","author":"care. Gott M; E, Galena; S, Hinchliff; H, Elford","year":"2004","unstructured":"Journal Club Opening a can of worms\u201d: GP and practice nurse barriers to talking about sexual health in primary care. Gott M, Galena E, Hinchliff S, Elford H. Fam Pract 2004; 21: 528\u2013536","journal-title":"Fam Pract"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.olq.0000137904.56037.70","article-title":"Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections","volume":"31","author":"CS, Bright P.; EL, Wong; C, Kwok; I, Yacobson; CA, Gaydos","year":"2004","unstructured":"Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Morrison CS, Bright P, Wong EL, Kwok C, Yacobson I, Gaydos CA, et al. Sex Transm Dis 2004; 31: 561\u2013567","journal-title":"et al. Sex Transm Dis"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1783\/0000000052972799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:15:16Z","timestamp":1757099716000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1783\/0000000052972799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,1,1]]},"published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1783\/0000000052972799"],"URL":"https:\/\/doi.org\/10.1783\/0000000052972799","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"value":"1471-1893","type":"print"},{"value":"2045-2098","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}